A randomized, double-blind, placebo-controlled study evaluating the effects of quercetin-rich onions on cognitive function in elderly subjects

Functional Foods in Health and Disease

Volumn 7, Issue 6, 2017, Pages 353-374

  Nishimura, Mie ^a   Ohkawara, Tatsuya ^a   Nakagawa, Toshiyuki ^b   Muro, Takato ^c   Sato, Yuji ^a   Satoh, Hiroki ^a   Kobori, Masuko ^d   Nishihira, Jun ^a  

^a HOKKAIDO INFORMATION UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL AGRICULTURAL RESEARCH CENTER FOR HOKKAIDO REGION   (Japan)

^d FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Clinical trial; Cognitive function; Mild cognitive impairment; Mini Mental, State Examination; Onion; Quercetin

Indexed keywords

EID: 85044983918     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v7i6.334     Document Type: Article

References (42)

1. A few previous studies have reported the effects of quercetin on cognitive function [13, 18, 19]. Additionally, a previous clinical trial has focused on its effect on cognitive function in patients with early stage AD [28]. It is important to confirm the effect of quercetin-rich onions, which are present in the usual diets of elderly. Therefore, this 24-week, randomized, double-blind, placebo-controlled trial was conducted to determine the effects of consuming quercetin-rich onions on cognitive function in elderly subjects.
2. WHO Organization: Dementia: A Public Health Priority. Switzerland; 2012.
3. Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G,… Sachdev PS: Cohort Studies of Memory in an International C.Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med 2017;14:e1002261. https://doi.org/10.1371/journal.pmed.1002261.
4. Pase MP, Grima N, Cockerell R, Stough C, Scholey A, Sali A, Pipingas A: The effects of long-chain omega-3 fish oils and multivitamins on cognitive and cardiovascular function: a randomized, controlled clinical trial. J Am Coll Nutr 2015, 34: 21-31.
5. Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Flöel A: Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014, 24:3059-3068.
6. Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L: Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Biochim Biophys Acta 2015, 1852:1202-1208.
7. Ribeiro ML, Moreira LM, Arçari DP, Dos Santos LF, Marques AC, Pedrazzoli J, Cerutti SM: Protective effects of chronic treatment with a standardized extract of Ginkgo biloba L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats. Behav Brain Res 2016, 313:144-150.
8. Häkkinen SH, Kärenlampi SO, Heinonen IM, Mykkänen HM, Törrönen AR: Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 1999,47:2274-2279.
9. Boots AW, Haenen GR, Bast A: Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008, 585:325-337.
10. Dong YS, Wang JL, Feng DY, Qin HZ, Wen H, Yin ZM, Gao GD, Li C: Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci 2014, 11:282-290.
11. Meyers KJ, Rudolf JL, Mitchell AE: Influence of dietary quercetin on glutathione redox status in mice. J Agric Food Chem 2008, 56:830-836.
12. Kobori M, Masumoto S, Akimoto Y, Oike H: Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 2011, 55:530-540.
13. Zhang M, Xie Z, Gao W, Pu L, Wei J, Guo C: Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats. Nutr Res 2016, 36:271-279.
14. Hayakawa M, Itoh M, Ohta K, Li S, Ueda M, Wang MX, Nishida E, Islam S, Suzuki C, Ohzawa K, Kobori M, Inuzuka T, Nakagawa T: Quercetin reduces eIF2α phosphorylation by GADD34 induction. Neurobiol Aging 2015, 36: 2509-2518.
15. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I: Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010, 501:79-90.
16. de Boer VC, de Goffau MC, Arts IC, Hollman PC, Keijer J: SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev 2006, 127:618-627.
17. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T: Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010, 75:764-770. https://doi.org/10.1212/WNL.0b013e3181eee25f
18. Henagan TM, Lenard NR, Gettys TW, Stewart LK: Dietary quercetin supplementation in mice increases skeletal muscle PGC1α expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner. PLoS One 2014, 9:e89365. https://doi.org/10.1371/journal.pone.0089365
19. Bhutada P, Mundhada Y, Bansod K, Bhutada C, Tawari S, Dixit P, Mundhada D: Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem 2010, 94:293-302.
20. Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Shan Q, Zheng ZH, Liu CM, Wang YJ: Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol 2010, 222:199-212.
21. Rice-Evans CA, Miller NJ: Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 1996, 24:790-795.
22. Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J: Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001, 133:117-124.
23. Kim SH, Jo SH, Kwon YI, Hwang JK: Effects of onion (Allium cepa L.) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in SD rats model. Int J Mol Sci 2011, 12:3757-3769.
24. Azuma K, Minami Y, Ippoushi K, Terao J: Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats. J Clin Biochem Nutr 2007, 40:131-140.
25. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N: Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 2000, 130:2243-2250.
26. Juźwiak S, Wójcicki J, Mokrzycki K, Marchlewicz M, Białecka M, Wenda-Rózewicka L, Gawrońska-Szklarz B, Droździk M: Effect of quercetin on experimental hyperlipidemia and atherosclerosis in rabbits. Pharmacol Rep 2005, 57:604-609.
27. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM: Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2004, 2:2138-2145.
28. Nishimuro H, Ohnishi H, Sato M, Ohnishi-Kameyama M, Matsunaga I, Naito S, Ippoushi K, Oike H, Nagata T, Akasaka H, Saitoh S, Shimamoto K, Kobori M: Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients 2015, 7:2345-2358.
29. Nakagawa T, Itoh M, Ohta K, Hayashi Y, Hayakawa M, Yamada Y, et al.: Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients. Neuroreport 2016, 27:671-676.
30. Soubelet A, Salthouse TA: Correlates of level and change in the Mini-Mental State Examination. Psychol Assess 2011, 23:811-818.
31. Murai T, Yamaguchi T, Maki Y, Isahai M, Kaiho Sato A, Yamagami T, Ura C, Miyamae F, Takahashi R, Yamaguchi H: Prevention of cognitive and physical decline by enjoyable walking-habituation program based on brain-activating rehabilitation. Geriatr Gerontol Int 2016, 16:701-708.
32. Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M: Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation. Psychogeriatrics 2016, 16:85-92.
33. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, Almeida OP: Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008, 300, 1027-1037.
34. Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO: Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2014, 39:271-282.
35. Suzuki T, Shimada H, Makizako H, Doi T, Yoshida D, Ito K, Shimokata H, Washimi Y, Endo H, Kato T: A randomized controlled trial of multicomponent exercise in older adults with mild cognitive impairment. PLoS One 2013, 8:e61483. https://doi.org/10.1371/journal.pone.0061483
36. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993, 269:2386-2391.
37. Lee LK, Shahar S, Chin AV, Yusoff NA: Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2013, 225:605-612.
38. Snitz BE, O'Meara ES, Carlson MC, Arnold AM, Ives DG, Rapp SR, Saxton J, Lopez OL, Dunn LO, Sink KM, DeKosky ST: Ginkgo Evaluation of Memory (GEM) Study Investigators: Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009, 302:2663-2670.
39. Siriwardhana N, Kalupahana NS, Cekanova M, LeMieux M, Greer B, Moustaid-Moussa N: Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 2013, 24:613-623.
40. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hänninen T, Soininen H, Kervinen K, Kesäniemi YA, Laakso M, Kuusisto J: Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006, 67:843-847.
41. Dekker AD, Strydom A, Coppus AM, Nizetic D, Vermeiren Y, Naudé PJ, Van Dam D, Potier MC, Fortea J, De Deyn PP: Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease? Cortex 2015, 73:36-61.
42. Tanaka H, Hashimoto M, Fukuhara R, Ishikawa T, Yatabe Y, Kaneda K, Yuuki S, Honda K, Matsuzaki S, Tsuyuguchi A, Hatada Y, Ikeda M: Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease. Psychogeriatrics 2015, 15:242-247.